The US regulator allowed vaccination with different drugs in rare cases

According to the publication, the interval between introducing the first and second doses of the vaccine can be extended to six weeks.

The US Centers for Disease Control and Prevention (CDC) has updated its recommendations for the coronavirus, allowing two different vaccine types to be administered to a single patient in exceptional cases. This was reported on Friday by The New York Times.

According to her, in addition to this change, the interval between introducing the first and second doses of the vaccine can be increased to six weeks. “The message is not to suggest that we act differently, but to give doctors more flexibility in exceptional cases,” CDC spokeswoman Kristen Nordlund said. At the same time, it is noted that the question of the effectiveness and safety of mixing the two types of vaccines has not yet been fully studied.

Currently, the Food and Drug Administration of the US Department of Health and Human Services has approved the use of a vaccine developed by Pfizer and BioNTech and the Moderna vaccine in the country. According to the latest CDC data, more than 15 million people in the United States have been given at least one dose of the vaccine, of which 2 million have received both doses of the vaccine.

Author: Steve Cowan
Graduated From Princeton University. He has been at the Free Press since October 2014. Previously worked as a regional entertainment editor.
Function: Chief-Editor
E-mail: Great7news@gmail.com